Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Assessment of the effect of drug formulation on the extent of the pharmacokinetic interaction between voriconazole and tacrolimus. - TacroVori

Next Previous
X
Search
Trial Profile

Assessment of the effect of drug formulation on the extent of the pharmacokinetic interaction between voriconazole and tacrolimus. - TacroVori

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 18 Aug 2022

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tacrolimus (Primary) ; Tacrolimus (Primary) ; Tacrolimus (Primary) ; Tacrolimus (Primary) ; Voriconazole
  • Indications Allergic conjunctivitis; Allotransplant rejection; Atopic dermatitis; Coronary artery restenosis; Eye disorders; Graft-versus-host disease; Interstitial lung diseases; Intestinal transplant rejection; Liver transplant rejection; Lupus nephritis; Myasthenia gravis; Open-angle glaucoma; Renal transplant rejection; Rheumatoid arthritis; Transplant rejection; Ulcerative colitis
  • Focus Pharmacokinetics
  • Acronyms TacroVori

    • Most Recent Events

    • 28 Jun 2022 Results presented at the 15th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT) 2022
    • 01 Oct 2018 Status changed from recruiting to completed.
    • 24 Apr 2017 Status changed from not yet recruiting to recruiting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top